Post-approval studies (Phase 4)UnknownNCT01746992
What this trial is testing
CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma
Who this might be right for
ALK-negative Anaplastic Large Cell LymphomaPeripherial T Cell Lymphoma,Not Otherwise SpecifiedAngioimmunoblastic T Cell Lymphoma+3 more
Ruijin Hospital 200